ARWR
ARROWHEAD PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$58.98
+1.65%Leverage
- Debt / equity
- 1.86x
- Net debt / equity
- 1.74x
- Debt / assets
- 0.41x
- Debt / EBITDA
- -6.46x
- Net debt / EBITDA
- -6.05x
Liquidity & coverage
- Current ratio
- 5.90x
- Quick ratio
- 5.90x
- Cash ratio
- 5.65x
- Interest coverage
- -2.45x
- EBITDA / interest
- -1.44x
- Working capital
- $1.4B
Cash & dividend
- FCF / debt
- -0.09x
- Cash flow / debt
- -0.07x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026